New York, New York (PRWEB) January 31, 2013
For the first time, Chief Medical Officers at biotechs will have their own conference thanks to the idea from Dr Elizabeth Stoner, Managing Director of MPM Capital. Valerie Bowling, Executive Director of The Conference Forum, the organizer of the event says, “We are grateful to Dr Stoner’s idea for the conference and her insights into the unique challenges CMOs face every day at small to mid-size biotechs.”
The Chief Medical Officer Summit takes place in Boston on May 6-7, 2013 and is dedicated to accomplishing two goals:
1. To bring together CMO executives to address the unique challenges associated with directing and managing all R&D functions with limited resources, while raising capital, working and meeting with investors and strategsing for appropriate exits.
2. To create a network of CMOs from small to mid size life science companies to share ideas, solutions and support.
Dr Steven Zelenkofske, CMO & SVP Clinical and Medical Affairs, Regado Biosciences and advisor to the program remarked, "I am excited about this conference and think it is very much needed."
Event Details: May 6-7, Boston, MA
The event organizers are offering a 10% discount with code CMOE and a pre-early bird rate before 3/1. Click here to register.
Jodi Black, PhD, Deputy Director, Division of Extramural Research Activities, National Heart, Lung, and Blood Institute, NIH
Mark Corrigan, MD, President & CEO, Zalicus
Anthony Coyle, PhD, VP & CSO, Centers for Therapeutic Innovation, Pfizer
Daniel Curran, MD, VP, Corporate Development, Millennium, Takeda Oncology
Greg Fiore, MD, CMO, The Medicines Company
Ken Getz, MBA, Senior Research Fellow, Tufts
Sheila Gujrathi, MD, CMO, Receptos
M. Scott Harris, MD, CMO, Avaxia Biologics; Principal, Middleburg Consultants; and Clinical Professor of Medicine, Georgetown University School of Medicine
Eric Hedrick, MD, CMO, Epizyme
Karin Hehenberger, MD, PhD, Executive Vice President & CMO, Coronado Biosciences
Dennis Kim, MD, MBA, CMO, Zafgen
Chris Kiritsy, MBA, President & CEO, Arisaph
Lori Kunkel, MD, CMO, Pharmacyclics
Tyler Martin, MD, President, CMO & Director, Dynavax Technologies
Robert Pyke, MD, PhD, CMO, S1 Biopharma
Jim Roach, MD, CMO & Senior Vice President, Development, Momenta Pharmaceuticals
Oscar Segurado, MD, PhD, CMO, Crescendo Bioscience
Jeffrey Sherman, MD, FACP, CMO & Executive Vice President, Development, Manufacturing, and Regulatory Affairs, Horizon Pharma
Greg Simon, CEO, Poliwogg
Elizabeth Stoner, MD, Managing Director, MPM Capital
Mary Szela, MBA, Senior Vice President, Pharmaceutical Operations, Abbott Laboratories
Santosh Vetticaden, MD, PhD, CMO, ADVENTRX Pharmaceuticals
Nancy Wetherbee, MBA, ORBIT Director, Tufts Medical Center
Steven Zelenkofske, DO, FACC, CMO & Senior Vice President, Clinical and Medical Affairs, Regado Bioscience
About The Conference Forum:
The Conference Forum has a very specific focus – developing specialized events both public and private as well as research groups and advisory boards for professionals in the life science industry. We currently offer conferences for R&D leaders, Clinical Development professionals, young and established Biotech executives, and Drug Delivery specialists. Our mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for Pharmaceutical and Biotech professionals.
Read the full story at http://www.prweb.com/releases/2013/1/prweb10373318.htm.
Copyright©2012 Vocus, Inc.
All rights reserved